Platelet Transfusion Guidelines
Indications for Platelet Transfusion
- The American Society of Clinical Oncology recommends transfusing platelets prophylactically when the count is <10 × 10⁹/L in patients with hypoproliferative thrombocytopenia (chemotherapy or allogeneic stem cell transplant) without active bleeding, with evidence of high certainty 2
- The American College of Cardiology suggests that platelet transfusion is indicated for patients with active bleeding, with a target platelet count of >50-75 × 10⁹/L, depending on the severity of the bleeding 1
- Higher thresholds are justified when there are signs of hemorrhage, high fever, hyperleukocytosis, rapid decline in platelet count, coagulation abnormalities, or planned invasive procedures 2
Dosing and Administration
- The standard adult dose is 3-4 × 10¹¹ platelets (one apheresis unit or 4-6 pooled units) 2, 3
- Low-dose prophylactic transfusions (half a unit) provide equivalent hemostasis but require more frequent administration 3
- The platelet count should increase by approximately 30 × 10⁹/L after a standard dose 1, 5
Special Considerations
- In patients with immune thrombocytopenic purpura, prophylactic transfusion is ineffective due to short platelet survival; useful only for severe bleeding 3
- In patients with thrombotic thrombocytopenic purpura, transfusion is relatively contraindicated due to the risk of precipitating thrombosis 2
- In patients with autoimmune or drug-associated thrombocytopenia, transfusion is rarely necessary in hemodynamically stable patients 2
Post-Transfusion Monitoring
- Repeat platelet count after transfusion to confirm adequate increment 1, 2
- Consider HLA-compatible platelets for patients with poor increments due to alloimmunization 3
Technical Precautions
- Infuse through a 170-200 μm filter over 30 minutes 1, 5
- Do not use equipment previously used for red blood cells 1, 5
- Do not add medications directly to the platelet unit 1, 5
- Store at 22°C with constant agitation; do not refrigerate 1, 5